Login to Your Account

OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid

By Cormac Sheridan
Staff Writer

Tuesday, October 23, 2012
The management of Dutch drug delivery specialist OctoPlus NV agreed to a €27.4 million (US$35.8 million) cash offer from Indian generics firm Dr. Reddy's Laboratories Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription